Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity
- PMID: 2820827
- DOI: 10.1016/0016-5085(87)90570-1
Brain gamma-aminobutyric acid receptor binding is normal in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma gamma-aminobutyric acid-like activity
Abstract
Brain gamma-aminobutyric acid (GABA) receptor density, affinity, and function, and plasma GABA-like activity were determined in rats with acute hepatic encephalopathy induced by an intraperitoneal injection of thioacetamide. In addition, the effect of various stress factors on brain GABA binding was assessed. Plasma GABA-like activity was significantly increased in rats with thioacetamide-induced hepatic encephalopathy compared with rats injected with vehicle alone (1506 +/- 993 nM, n = 7 vs. 367 +/- 97 nM, n = 9, mean +/- SD; p less than 0.001). In contrast, there were no alterations in either brain GABA receptor binding or in GABA-enhanced benzodiazepine binding in rats with hepatic encephalopathy when compared with relevant controls. However, rats that had received intraperitoneal injections of thioacetamide or vehicle (0.15 M NaCl) had significantly more low-affinity GABA receptors than rats that had neither been injected nor handled before killing (8769 +/- 1101 vs. 2710 +/- 757 fmol/mg protein, mean +/- SEM, p less than 0.001). We concluded that stress factors appear to be important causes of altered brain GABA binding. Brain GABA receptor binding and function, however, are unaltered in rats with thioacetamide-induced hepatic encephalopathy despite elevated plasma GABA-like activity.
Similar articles
-
Plasma GABA, GABA-like activity and the brain GABA-benzodiazepine receptor complex in rats with chronic hepatic encephalopathy.Hepatology. 1987 Jul-Aug;7(4):621-8. doi: 10.1002/hep.1840070402. Hepatology. 1987. PMID: 3038721
-
Hepatic encephalopathy in thioacetamide-induced acute liver failure in rats: characterization of an improved model and study of amino acid-ergic neurotransmission.Hepatology. 1989 Apr;9(4):594-601. doi: 10.1002/hep.1840090414. Hepatology. 1989. PMID: 2564368
-
GABAA receptor complex in an experimental model of hepatic encephalopathy: evidence for elevated levels of an endogenous benzodiazepine receptor ligand.J Neurochem. 1989 Oct;53(4):1057-63. doi: 10.1111/j.1471-4159.1989.tb07395.x. J Neurochem. 1989. PMID: 2549194
-
NIH conference. The gamma-aminobutyric acid A (GABAA) receptor complex and hepatic encephalopathy. Some recent advances.Ann Intern Med. 1989 Apr 1;110(7):532-46. doi: 10.7326/0003-4819-110-7-532. Ann Intern Med. 1989. PMID: 2538099 Review.
-
Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy.Metab Brain Dis. 2002 Dec;17(4):275-81. doi: 10.1023/a:1021949616422. Metab Brain Dis. 2002. PMID: 12602504 Review.
Cited by
-
Pathogenesis of hepatic encephalopathy.Metab Brain Dis. 1987 Sep;2(3):147-65. doi: 10.1007/BF00999607. Metab Brain Dis. 1987. PMID: 2905418 Review. No abstract available.
-
Improvement of chronic hepatic encephalopathy in dogs by the benzodiazepine-receptor partial inverse agonist sarmazenil, but not by the antagonist flumazenil.Metab Brain Dis. 1998 Sep;13(3):241-51. doi: 10.1023/a:1023228126315. Metab Brain Dis. 1998. PMID: 9804368
-
Endogenous GABAergic modulators in the pathogenesis of hepatic encephalopathy.Neurochem Res. 1990 Feb;15(2):193-7. doi: 10.1007/BF00972209. Neurochem Res. 1990. PMID: 2159124 Review.
-
Effect of hepatic insufficiency on pharmacokinetics and drug dosing.Pharm World Sci. 1998 Oct;20(5):183-92. doi: 10.1023/a:1008656930082. Pharm World Sci. 1998. PMID: 9820880 Review.
-
Fulminant liver failure model with hepatic encephalopathy in the mouse.Ann Gastroenterol. 2011;24(4):294-306. Ann Gastroenterol. 2011. PMID: 24713795 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources